Form EFFECT RetinalGenix Technologie
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 27, 2025 |
| Accession Number: | 0001641172-25-015960 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VistaShares BitBonds™ 5 Yr Enhanced Weekly Option Income ETF (BTYB) to Close
- Lineage, Inc. Declares Dividend for Second-Quarter 2026
- NewLake Capital Partners Issues Second Quarter 2026 Common Stock Dividend of $0.43 per Share
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
